Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
Author(s) -
Bradley A. Maron,
Edward Hess,
Thomas M. Maddox,
Alexander R. Opotowsky,
Ryan J. Tedford,
Tim Lahm,
Karen E. Joynt,
Daniel J. Kass,
Thomas Stephens,
Maggie A. Stanislawski,
Erik R. Swenson,
Ronald H. Goldstein,
Jane A. Leopold,
Roham T. Zamanian,
Jean Elwing,
Mary E. Plomondon,
Gary K. Grunwald,
Anna E. Barón,
John S. Rumsfeld,
Gaurav Choudhary
Publication year - 2016
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.115.020207
Subject(s) - medicine , hazard ratio , confidence interval , pulmonary hypertension , veterans affairs , proportional hazards model , cardiology , cohort , pulmonary artery
Pulmonary hypertension (PH) is associated with increased morbidity across the cardiopulmonary disease spectrum. Based primarily on expert consensus opinion, PH is defined by a mean pulmonary artery pressure (mPAP) ≥25 mm Hg. Although mPAP levels below this threshold are common among populations at risk for PH, the relevance of mPAP <25 mm Hg to clinical outcome is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom